Literature DB >> 18210023

[Prevention of gastrointestinal malignancies].

A Hoffmeister1, I Schiefke, N Teich, J Mössner, K Schoppmeyer.   

Abstract

Malignancies of the gastrointestinal tract are the most common causes of cancer-related deaths in Germany. They also induce significant morbidity. Despite both surgical and medical therapeutic improvements, advanced stages of these cancers can rarely be cured. Preventive and screening measures are suitable to decrease gastrointestinal cancer-related mortality. Weight reduction and cessation of smoking are effective in preventing esophageal, pancreatic and colorectal cancer. Treatment of infections like chronic viral hepatitis and helicobacter pylori gastritis is able to protect from hepatocellular and gastric cancer, respectively. Colonoscopy is one of the best established screening methods. It allows early detection of colorectal neoplasia. Preneoplastic adenomas can be endoscopically removed during the same session. We here review simple prevention strategies and effective screening methods in gastrointestinal cancers of relevance in daily practice.

Entities:  

Mesh:

Year:  2008        PMID: 18210023     DOI: 10.1007/s00108-007-1998-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  18 in total

1.  [S3-Guidelines "Exocrine pancreatic cancer" 2007].

Authors:  G Adler; T Seufferlein; S C Bischoff; H-J Brambs; S Feuerbach; G Grabenbauer; S Hahn; V Heinemann; W Hohenberger; J M Langrehr; M P Lutz; O Micke; H Neuhaus; P Neuhaus; H Oettle; P M Schlag; R Schmid; W Schmiegel; K Schlottmann; J Werner; B Wiedenmann; I Kopp
Journal:  Z Gastroenterol       Date:  2007-06       Impact factor: 2.000

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  A prospective study of cigarette smoking and the risk of pancreatic cancer.

Authors:  C S Fuchs; G A Colditz; M J Stampfer; E L Giovannucci; D J Hunter; E B Rimm; W C Willett; F E Speizer
Journal:  Arch Intern Med       Date:  1996-10-28

Review 4.  Screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B P Towler; L Irwig; P Glasziou; D Weller; J Kewenter
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.

Authors:  Mats Lindblad; Luis A García Rodríguez; Jesper Lagergren
Journal:  Cancer Causes Control       Date:  2005-04       Impact factor: 2.506

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 7.  Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.

Authors:  Wei Hong Wang; Jia Qing Huang; Ge Fan Zheng; Shiu Kum Lam; Johan Karlberg; Benjamin Chun-Yu Wong
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

8.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

9.  [Current epidemiology of carcinoma of the esophagus and cardia in Germany].

Authors:  D Bareiss; R Stabenow; R Müller; B Eisinger; C Stegmaier; P Däubler; M Zeitz; H Scherübl
Journal:  Dtsch Med Wochenschr       Date:  2002-06-21       Impact factor: 0.628

10.  Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan.

Authors:  K Tanaka; T Hirohata; S Takeshita; I Hirohata; S Koga; K Sugimachi; T Kanematsu; F Ohryohji; H Ishibashi
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

View more
  1 in total

Review 1.  Does smoking reduce infliximab's effectiveness against Crohn's disease?

Authors:  Neeraj Narula; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.